CompletedPhase 4ACTRN12609000996268
Randomized prospective trial of cyclosporine with/without low-dose prednisolone in idiopathic membranous nephropathy in adults with nephrotic syndrome
Sponsor
Research Group for Treatments of Kidney Diseases in Ibaraki, Japan
Enrollment
30 participants
Start Date
Jun 1, 2000
Study Type
Interventional
Conditions
Eligibility
Sex: Both males and femalesMin Age: 16 YearssMax Age: 80 Yearss
Plain Language Summary
Simplified for easier understanding
This study compares two treatments for idiopathic membranous nephropathy, a kidney disease that causes protein to leak into the urine. Adults aged 16 to 80 with a confirmed diagnosis and high protein levels in the urine will receive either cyclosporine alone or cyclosporine with low-dose prednisolone.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Oral administration of cyclosporine 3 mg/kg/day and prednisolone 15 mg/day, for a total of 24 months
Oral administration of cyclosporine 3 mg/kg/day and prednisolone 15 mg/day, for a total of 24 months
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12609000996268